Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Pulmonary Hypertension, February 2022 Free Subscription Abstracts Retrieve all available abstracts of the following 174 articles: HTML format

Single Articles

1. STEFFES LC, Kumar ME
   Chronic Daily House Dust Mite Exposure in Mice is an Effective Model to Quantify the Effect of Pharmacologic Agents on Discrete Stages of Artery Remodeling in Pulmonary Hypertension.
   Bio Protoc. 2022;12:e4273.
   PubMed    
   Abstract available
   
   

2. FARRELL C, Balasubramanian A, Hays AG, Hsu S, et al
   A Clinical Approach to Multimodality Imaging in Pulmonary Hypertension.
   Front Cardiovasc Med. 2022;8:794706.
   PubMed    
   Abstract available
   
   

3. WANG J, Zhang Z, Liang C, Lv T, et al
   Targeting Myadm to Intervene Pulmonary Hypertension on Rats Before Pregnancy Alleviates the Effect on Their Offspring's Cardiac-Cerebral Systems.
   Front Pharmacol. 2022;12:791370.
   PubMed    
   Abstract available
   
   

4. ZHANG S, Tong X, Zhang T, Wang D, et al
   Prevalence of Sarcoidosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis.
   Front Cardiovasc Med. 2022;8:809594.
   PubMed    
   Abstract available
   
   

5. KROEGER JR, Zollner J, Gerhardt F, Rosenkranz S, et al
   Detection of patients with chronic thromboembolic pulmonary hypertension by volumetric iodine quantification in the lung-a case control study.
   Quant Imaging Med Surg. 2022;12:1121-1129.
   PubMed    
   Abstract available
   
   

6. ZHANG L, Dai J, Zhang P, Ma H, et al
   Right ventricular end-systolic remodeling index on cardiac magnetic resonance imaging: comparison with other functional markers in patients with chronic thromboembolic pulmonary hypertension.
   Quant Imaging Med Surg. 2022;12:894-905.
   PubMed    
   Abstract available
   
   

7. TAMURA Y, Tamura Y
   Dasatinib-induced Pulmonary Hypertension.
   Intern Med. 2022 Feb 1. doi: 10.2169/internalmedicine.9107.
   PubMed    
   
   
   

8. RASHIDI F, Parvizi R, Bilejani E, Mahmoudian B, et al
   Outcome of Surgery for Chronic Thromboembolic Pulmonary Disease without Pulmonary Hypertension.
   Thorac Cardiovasc Surg. 2022 Feb 2. doi: 10.1055/s-0041-1740560.
   PubMed    
   Abstract available
   
   

9. SCHULZE KM, Weber RE, Horn AG, Colburn TD, et al
   Effects of pulmonary hypertension on microcirculatory hemodynamics in rat skeletal muscle.
   Microvasc Res. 2022 Jan 29:104334. doi: 10.1016/j.mvr.2022.104334.
   PubMed    
   Abstract available
   
   

10. JOSEPH C, Berghausen EM, Behringer A, Rauch B, et al
    Coagulation-independent effects of thrombin and factor Xa: role of protease-activated receptors in pulmonary hypertension.
    Cardiovasc Res. 2022 Feb 1. pii: 6519149. doi: 10.1093.
    PubMed    
    Abstract available
    
    

11. HUANG Y, Lin F, Tang R, Bao C, et al
    Gut Microbial Metabolite Trimethylamine N-Oxide Aggravates Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2022 Jan 31. doi: 10.1165/rcmb.2021-0414.
    PubMed    
    Abstract available
    
    

12. YUAN YP, Yuan P, Su YL, Jiang R, et al
    Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
    Clin Rheumatol. 2022 Jan 31. pii: 10.1007/s10067-021-06016.
    PubMed    
    Abstract available
    
    

13. CRITSER PJ, Boyer D, Visner GA, Collins SL, et al
    Recovery of right ventricular function after bilateral lung transplantation for pediatric pulmonary hypertension.
    Pediatr Transplant. 2022 Jan 31:e14236. doi: 10.1111/petr.14236.
    PubMed    
    Abstract available
    
    

14. LUONGO F, Miotti C, Scoccia G, Papa S, et al
    Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension.
    Heart Fail Rev. 2022 Jan 31. pii: 10.1007/s10741-021-10208.
    PubMed    
    Abstract available
    
    

15. HATANO M, Abe K, Koike G, Takahashi T, et al
    Positive Predictors for Response to Ambrisentan Combination Therapy in Pulmonary Arterial Hypertension.
    Int Heart J. 2022;63:99-105.
    PubMed    
    Abstract available
    
    

16. OKA T, Nakanishi R, Kabuki T, Hashimoto H, et al
    Appropriate Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension Improves Right Ventricular Ejection Fraction via Lung Perfusion Scan.
    Int Heart J. 2022;63:91-98.
    PubMed    
    Abstract available
    
    

17. YE H, Wu Q, Zhang N, Shi J, et al
    The prognostic value of sST2 in connective tissue disease patients with pulmonary hypertension.
    Rheumatology (Oxford). 2022 Jan 30. pii: 6517499.
    PubMed    
    Abstract available
    
    

18. CHEN D, Yuan T, Chen Y, Zhang H, et al
    DL0805-1, a novel Rho-kinase inhibitor, attenuates lung injury and vasculopathy in a rat model of monocrotaline-induced pulmonary hypertension.
    Eur J Pharmacol. 2022 Jan 26:174779. doi: 10.1016/j.ejphar.2022.174779.
    PubMed    
    Abstract available
    
    

19. WANG Q, Sun YY, Huang YX, Wang L, et al
    Prognostic Value of Follicle-Stimulating Hormone Levels in Predicting Survival in Men With Idiopathic Pulmonary Arterial Hypertension.
    Am J Mens Health. 2022;16:15579883211067084.
    PubMed    
    Abstract available
    
    

20. MELZIG C, Rengier F
    [Increased pulmonary arterial and venous pressure].
    Radiologe. 2022;62:120-129.
    PubMed    
    Abstract available
    
    

21. PENOV K, Radakovic D, Karimli S, Aleksic I, et al
    Fibrin Sealant Patch for the Management of Intractable Bleeding From an LVAD Apex Cannula.
    Heart Surg Forum. 2021;24:E1052-E1053.
    PubMed    
    Abstract available
    
    

22. ARVANITAKI A, Diller GP
    The use of pulmonary arterial hypertension therapies in Eisenmenger syndrome.
    Expert Rev Cardiovasc Ther. 2021;19:1053-1061.
    PubMed    
    Abstract available
    
    

23. ROLLER FC, Schussler A, Hasse A, Kriechbaum S, et al
    Effects of BPA on right ventricular mechanical dysfunction in patients with inoperable CTEPH - A cardiac magnetic resonance study.
    Eur J Radiol. 2021;147:110111.
    PubMed    
    Abstract available
    
    

24. ZEYNALYAN AA, Kolasani B, Naik C, Sigakis CJG, et al
    Rapidly progressive respiratory failure after helminth larvae ingestion.
    BMC Pulm Med. 2021;21:422.
    PubMed    
    Abstract available
    
    

25. WANG T, Duan Y, Liu D, Li G, et al
    The effect of transglutaminase-2 inhibitor on pulmonary vascular remodeling in rats with pulmonary arterial hypertension.
    Clin Exp Hypertens. 2021 Dec 10:1-8. doi: 10.1080/10641963.2021.2013493.
    PubMed    
    Abstract available
    
    

26. XIN Z, Wang J, Li S, Sun C, et al
    A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension.
    Clin Exp Hypertens. 2021 Nov 25:1-6. doi: 10.1080/10641963.2021.1996590.
    PubMed    
    Abstract available
    
    

27. DARDI F, Manes A, Guarino D, Zuffa E, et al
    A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
    Open Heart. 2021;8.
    PubMed    
    Abstract available
    
    

28. DESHWAL H, Weinstein T, Sulica R
    Advances in the management of pulmonary arterial hypertension.
    J Investig Med. 2021;69:1270-1280.
    PubMed    
    Abstract available
    
    

29. EL-KERSH K, Dickinson JD
    Pulmonary arterial hypertension: promising advances and remaining challenges.
    J Investig Med. 2021;69:1268-1269.
    PubMed    
    
    
    

30. BERNAL-RAMIREZ J, Diaz-Vesga MC, Talamilla M, Mendez A, et al
    Exploring Functional Differences between the Right and Left Ventricles to Better Understand Right Ventricular Dysfunction.
    Oxid Med Cell Longev. 2021;2021:9993060.
    PubMed    
    Abstract available
    
    

31. MANSUETO G, Di Napoli M, Campobasso CP, Slevin M, et al
    Pulmonary arterial hypertension (PAH) from autopsy study: T-cells, B-cells and mastocytes detection as morphological evidence of immunologically mediated pathogenesis.
    Pathol Res Pract. 2021;225:153552.
    PubMed    
    Abstract available
    
    

32. SLOT E, Boers R, Boers J, van IJcken WFJ, et al
    Genome wide DNA methylation analysis of alveolar capillary dysplasia lung tissue reveals aberrant methylation of genes involved in development including the FOXF1 locus.
    Clin Epigenetics. 2021;13:148.
    PubMed    
    Abstract available
    
    

33. HU W, Zhao F, Chen L, Ni J, et al
    NAADP-induced intracellular calcium ion is mediated by the TPCs (two-pore channels) in hypoxia-induced pulmonary arterial hypertension.
    J Cell Mol Med. 2021;25:7485-7499.
    PubMed    
    Abstract available
    
    

34. SONG R, Lei S, Yang S, Wu SJ, et al
    LncRNA PAXIP1-AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axis.
    J Cell Mol Med. 2021;25:7321-7334.
    PubMed    
    Abstract available
    
    

35. WANG RS, Loscalzo J
    Network module-based drug repositioning for pulmonary arterial hypertension.
    CPT Pharmacometrics Syst Pharmacol. 2021;10:994-1005.
    PubMed    
    Abstract available
    
    

36. TOUJANI S, El Ouni A, Belhassan A, Ghriss N, et al
    [A rare cause of pulmonary arterial hypertension: Thoracic amyloidosis].
    Ann Cardiol Angeiol (Paris). 2022;71:59-62.
    PubMed    
    Abstract available
    
    

37. HU Z, Song Q, Ma H, Guo Y, et al
    TRIM32 inhibits the proliferation and migration of pulmonary artery smooth muscle cells through the inactivation of PI3K/Akt pathway in pulmonary arterial hypertension.
    J Bioenerg Biomembr. 2021;53:309-320.
    PubMed    
    Abstract available
    
    

38. CONDORI LEANDRO HI, Vakhrushev AD, Goncharova NS, Korobchenko LE, et al
    Stimulation Mapping of the Pulmonary Artery for Denervation Procedures: an Experimental Study.
    J Cardiovasc Transl Res. 2021;14:546-555.
    PubMed    
    Abstract available
    
    

39. DOYTCHINOVA A, Gerson M
    First steps in imaging the right ventricle with iodine-123-metaiodobenzylguanidine (123I-MIBG) and cadmium-zinc-telluride technology.
    J Nucl Cardiol. 2021;28:557-559.
    PubMed    
    
    
    

40. GIMELLI A, Pugliese NR, Bertasi M, Airo E, et al
    Cardio-pulmonary involvement in pulmonary arterial hypertension: A perfusion and innervation scintigraphic evaluation.
    J Nucl Cardiol. 2021;28:546-556.
    PubMed    
    Abstract available
    
    

41. DENG L, Chen J, Chen B, Wang T, et al
    LncPTSR Triggers Vascular Remodeling in Pulmonary Hypertension by Regulating [Ca2+]i in Pulmonary Arterial Smooth Muscle Cells.
    Am J Respir Cell Mol Biol. 2022 Feb 11. doi: 10.1165/rcmb.2020-0480.
    PubMed    
    Abstract available
    
    

42. CHEN Y, Zhao Y, Tanba C, Qi G, et al
    Undersized ballooning strategy for chronic thrombo-embolic pulmonary hypertension.
    Eur Heart J Case Rep. 2022;6:ytac034.
    PubMed    
    
    
    

43. PU S, Yin L, Wen B, He J, et al
    The Association of Body Mass Index With the Risk of Pulmonary Hypertension in Adults: A Systematic Review and Meta-Analysis of Observational Studies.
    Front Med (Lausanne). 2022;8:680223.
    PubMed    
    Abstract available
    
    

44. SMOLDERS VFED, Rodriguez C, Blanco I, Szulcek R, et al
    Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
    Sci Rep. 2022;12:2283.
    PubMed    
    Abstract available
    
    

45. ZHENG Z, Chen R, Sun X, Lu J, et al
    A Meta-analysis of the efficacy of pulmonary artery denervation in the treatment of pulmonary hypertension.
    Heart Lung. 2022;53:42-50.
    PubMed    
    Abstract available
    
    

46. YOO HHB, Marin FL
    Treating Inflammation Associated with Pulmonary Hypertension: An Overview of the Literature.
    Int J Gen Med. 2022;15:1075-1083.
    PubMed    
    Abstract available
    
    

47. SAVALE L, Huitema M, Shlobin O, Kouranos V, et al
    WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension.
    Eur Respir Rev. 2022;31.
    PubMed    
    Abstract available
    
    

48. YAMASAKI Y, Moriyama S, Tatsumoto R, Abe K, et al
    Chronic thromboembolic pulmonary hypertension after acute pulmonary thromboembolism revealed by dynamic chest radiography.
    Eur Heart J Cardiovasc Imaging. 2022 Feb 7. pii: 6523881.
    PubMed    
    
    
    

49. ALICI G, Genc O
    Prevalence and etiologies of pulmonary hypertension at Somalia-Turkey Training and Research Hospital in Mogadishu.
    Pan Afr Med J. 2021;40:215.
    PubMed    
    Abstract available
    
    

50. TANG Y, Huo X, Liu J, Tang Y, et al
    MicroRNA-325-3p Targets Human Epididymis Protein 4 to Relieve Right Ventricular Fibrosis in Rats with Pulmonary Arterial Hypertension.
    Cardiovasc Ther. 2022;2022:4382999.
    PubMed    
    Abstract available
    
    

51. FU WH, Chen PL, Xia JL, Fu L, et al
    [Efficacy and safety of endothelin receptor antagonists combined with phosphodiesterase 5 inhibitor in the treatment of pulmonary arterial hypertension: a network meta-analysis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:158-170.
    PubMed    
    Abstract available
    
    

52. TANAKA S, Yamamoto T, Mikawa M, Nawata J, et al
    Stabilization of RyR2 maintains right ventricular function, reduces the development of ventricular arrhythmias, and improves prognosis in pulmonary hypertension.
    Heart Rhythm. 2022 Feb 5. pii: S1547-5271(22)00119.
    PubMed    
    Abstract available
    
    

53. LUNARDI M, Wu S, Serruys PW, Onuma Y, et al
    Acute and chronic exercise training in patients with Class II pulmonary hypertension: effects on haemodynamics and symptoms.
    ESC Heart Fail. 2022 Feb 7. doi: 10.1002/ehf2.13819.
    PubMed    
    Abstract available
    
    

54. GAMRACY J, Wiggen K, Vientos-Plotts A, Reinero C, et al
    Clinicopathologic features, comorbid diseases, and prevalence of pulmonary hypertension in dogs with bronchomalacia.
    J Vet Intern Med. 2022 Feb 7. doi: 10.1111/jvim.16381.
    PubMed    
    Abstract available
    
    

55. OH S, Jung JH, Ahn KJ, Jang AY, et al
    Stem Cell and Exosome Therapy in Pulmonary Hypertension.
    Korean Circ J. 2022;52:110-122.
    PubMed    
    Abstract available
    
    

56. GUO W, Wang N, Cui Z, Liu W, et al
    Clinical Value of FeNO for Pulmonary Hypertension Diagnosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Emerg Med Int. 2022;2022:9924047.
    PubMed    
    Abstract available
    
    

57. BLANQUEZ-NADAL M, Piliero N, Guillien A, Salvat M, et al
    Neural respiratory drive in chronic thromboembolic pulmonary hypertension: Effect of balloon pulmonary angioplasty.
    Respir Physiol Neurobiol. 2022;299:103857.
    PubMed    
    Abstract available
    
    

58. WHITLOCK AE, Sheils CA, Zalieckas JM, Visner G, et al
    High altitude simulation testing in patients with congenital diaphragmatic hernia.
    J Pediatr Surg. 2021 Oct 29. pii: S0022-3468(21)00743.
    PubMed    
    Abstract available
    
    

59. MACHADO RD, Southgate L
    Pulmonary Arterial Hypertension: A Deeper Evaluation of Genetic Risk in the -Omics Era.
    Genes (Basel). 2021;12.
    PubMed    
    Abstract available
    
    

60. CERIK IB, Dindas F, Koyun E, Dereli S, et al
    New prognostic markers in pulmonary arterial hypertension: CRP to albumin ratio and uric acid.
    Clin Biochem. 2022;100:22-28.
    PubMed    
    Abstract available
    
    

61. JANSEN SMA, van de Heuvel LM, Houweling AC, van Tintelen JP, et al
    Uptake and Patient Perspectives on Additional Testing for Novel Disease-Associated Genes: Lessons from a PAH Cohort.
    Genes (Basel). 2021;12.
    PubMed    
    Abstract available
    
    

62. ZHU H, Sun X, Cao Y, Pudasaini B, et al
    Cardiopulmonary exercise testing and pulmonary function testing for predicting the severity of CTEPH.
    BMC Pulm Med. 2021;21:324.
    PubMed    
    Abstract available
    
    

63. ZHANG R, Li Z, Liu C, Yang Q, et al
    Pretreatment with the active fraction of Rhodiola tangutica (Maxim.) S.H. Fu rescues hypoxia-induced potassium channel inhibition in rat pulmonary artery smooth muscle cells.
    J Ethnopharmacol. 2022;283:114734.
    PubMed    
    Abstract available
    
    

64. CORBOZ MR, Plaunt AJ, Malinin V, Li Z, et al
    Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertension.
    Eur J Pharmacol. 2021 Sep 8:174484. doi: 10.1016/j.ejphar.2021.174484.
    PubMed    
    Abstract available
    
    

65. XU J, Wen X, Fu Z, Jiang Y, et al
    Chronic hypoxia promoted pulmonary arterial smooth muscle cells proliferation through upregulated calcium-sensing receptorcanonical transient receptor potential 1/6 pathway.
    Microcirculation. 2021;28:e12715.
    PubMed    
    Abstract available
    
    

66. HEKIMSOY V, Kilinc Hekimsoy H, Sekeroglu MA, Kaya EB, et al
    The relationship between retinal microcirculation and right heart catheterization and echocardiography findings in patients with idiopathic pulmonary arterial hypertension.
    Microcirculation. 2021;28:e12704.
    PubMed    
    Abstract available
    
    

67. LEE A, Patterson KA, Tan DJ, Wilson ME, et al
    Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients.
    Scand J Rheumatol. 2021;50:469-474.
    PubMed    
    Abstract available
    
    

68. MIYAMOTO K, Inai K, Kobayashi T, Maeda J, et al
    Outcomes of idiopathic pulmonary arterial hypertension in Japanese children: a retrospective cohort study.
    Heart Vessels. 2021;36:1392-1399.
    PubMed    
    Abstract available
    
    

69. HIRAM R, Xiong F, Naud P, Xiao J, et al
    The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.
    Cardiovasc Res. 2021;117:1776-1789.
    PubMed    
    Abstract available
    
    

70. ZHANG WT, Lu Q, Ding JJ, Gu M, et al
    Association of asymmetric dimethylarginine with the pathological process of persistent pulmonary hypertension of the newborn.
    Zhongguo Dang Dai Er Ke Za Zhi. 2022;24:54-59.
    PubMed    
    Abstract available
    
    

71. ABU T, Levi A, Hasdai D, Kramer MR, et al
    Preoperative evaluation of pulmonary hypertension in lung transplant candidates: echocardiography versus right heart catheterization.
    BMC Cardiovasc Disord. 2022;22:53.
    PubMed    
    Abstract available
    
    

72. QUAN R, Huang S, Pang L, Shen J, et al
    Risk prediction in pulmonary hypertension due to chronic heart failure: incremental prognostic value of pulmonary hemodynamics.
    BMC Cardiovasc Disord. 2022;22:56.
    PubMed    
    Abstract available
    
    

73. YANG LF, Chen DD, Wang GF, Long YL, et al
    [Efficacy of fenestrated atrial septal defect occulders on pulmonary hypertension dogs].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50:166-171.
    PubMed    
    Abstract available
    
    

74. CIPOLLETTA S, Ravasio G, Bussotti M
    Sexual and Reproductive Health in Women with Pulmonary Hypertension: A Qualitative Study.
    Arch Sex Behav. 2022 Feb 14. pii: 10.1007/s10508-022-02284.
    PubMed    
    Abstract available
    
    

75. SLAWEK-SZMYT S, Araszkiewicz A, Jankiewicz S, Smukowska-Gorynia A, et al
    Association of Electrocardiographic Signs of Right Ventricular Hypertrophy and Clot Localization in Chronic Thromboembolic Pulmonary Hypertension.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available
    
    

76. ALBANI S, Stolfo D, Venkateshvaran A, Chubuchny V, et al
    Echocardiographic Biventricular Coupling Index to Predict Pre-Capillary Pulmonary Hypertension.
    J Am Soc Echocardiogr. 2022 Feb 11. pii: S0894-7317(22)00061.
    PubMed    
    Abstract available
    
    

77. BERLIER C, Saxer S, Lichtblau M, Schneider SR, et al
    Influence of Upright Versus Supine Position on Resting and Exercise Hemodynamics in Patients Assessed for Pulmonary Hypertension.
    J Am Heart Assoc. 2022;11:e023839.
    PubMed    
    Abstract available
    
    

78. CHEN YJ, Lin YJ, Guo MM
    Pediatric Lupus Presenting as Pulmonary Hypertension, Myocarditis, and Massive Pericardial Effusion in an 11-Year-Old Girl: A Case Report and Literature Review.
    Front Pediatr. 2022;10:772422.
    PubMed    
    Abstract available
    
    

79. ALSOMALI F, Mushtaq S, Bakir M, Almustanyir S, et al
    Fruitful Pregnancy Outcome in a Case of Eisenmenger Syndrome With Severe Pulmonary Hypertension: A Rare Case Report.
    Cureus. 2022;14:e21068.
    PubMed    
    Abstract available
    
    

80. MEHRA P, Mehta V, Yusuf J, Sukhija R, et al
    Endothelin-1 gene and endothelin receptor A gene polymorphisms in severe pulmonary hypertension associated with rheumatic mitral valve disease.
    Arch Med Sci. 2022;18:260-266.
    PubMed    
    Abstract available
    
    

81. AGUIRRE-FRANCO C, Torres-Duque CA, Salazar G, Casas A, et al
    Prevalence of pulmonary hypertension in COPD patients living at high altitude.
    Pulmonology. 2022 Feb 9. pii: S2531-0437(22)00004.
    PubMed    
    Abstract available
    
    

82. JASINSKA-STROSCHEIN M
    A review of genetically-driven rodent models of pulmonary hypertension.
    Vascul Pharmacol. 2022 Feb 9:106970. doi: 10.1016/j.vph.2022.106970.
    PubMed    
    Abstract available
    
    

83. INDRALINGAM CS, Gutierrez-Gonzalez AK, Johns SC, Tsui T, et al
    IL-33/ST2 receptor-dependent signaling in the development of pulmonary hypertension in Sugen/hypoxia mice.
    Physiol Rep. 2022;10:e15185.
    PubMed    
    Abstract available
    
    

84. SHI Q, Wang Z, Yang N, Ma Y, et al
    Sildenafil for adult Asian patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
    Ann Palliat Med. 2022;11:339-351.
    PubMed    
    Abstract available
    
    

85. BELENJE A, Agarwal K
    Bilateral central retinal vein occlusion in a neonate secondary to atrial septal defect and patent ductus arteriosus.
    BMJ Case Rep. 2022;15.
    PubMed    
    
    
    

86. LEE JY, Lee SH, Kim WH
    Reversible severe tricuspid regurgitation associated with Graves' disease: A case report.
    Medicine (Baltimore). 2021;100:e28432.
    PubMed    
    Abstract available
    
    

87. HUMBERT M, Montani D, Savale L, Tu L, et al
    [Targeting activin receptor IIA ligands for the treatment of pulmonary arterial hypertension].
    Med Sci (Paris). 2021;37:839-843.
    PubMed    
    
    
    

88. LI A, He J, Zhang Z, Jiang S, et al
    Integrated Bioinformatics Analysis Reveals Marker Genes and Potential Therapeutic Targets for Pulmonary Arterial Hypertension.
    Genes (Basel). 2021;12.
    PubMed    
    Abstract available
    
    

89. EYRIES M, Girerd B, Savale L, Soubrier F, et al
    A CELSR1 variant in a patient with pulmonary arterial hypertension.
    Clin Genet. 2021;100:771-772.
    PubMed    
    
    
    

90. JOUEN-TACHOIRE TRH, Tucker SJ, Tammaro P
    Ion channels as convergence points in the pathology of pulmonary arterial hypertension.
    Biochem Soc Trans. 2021;49:1855-1865.
    PubMed    
    Abstract available
    
    

91. ARAI MA, Sakuraba K, Makita Y, Hara Y, et al
    Evaluation of Naturally Occurring HIF-1 Inhibitors for Pulmonary Arterial Hypertension.
    Chembiochem. 2021;22:2799-2804.
    PubMed    
    Abstract available
    
    

92. ARCOPINTO M, Marra AM
    Clinical and non-clinical determinants of pulmonary arterial hypertension development in severe autoimmune rheumatic diseases.
    Rheumatology (Oxford). 2021;61:1-2.
    PubMed    
    
    
    

93. ZHU N, Swietlik EM, Welch CL, Pauciulo MW, et al
    Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
    Genome Med. 2021;13:80.
    PubMed    
    Abstract available
    
    

94. KATEWA A, Sahu B, Gajpal S, Anderson RH, et al
    Total Anomalous Pulmonary Venous Connection and Aortopulmonary Window: Successful Management of a Rare Association.
    World J Pediatr Congenit Heart Surg. 2021;12:785-787.
    PubMed    
    Abstract available
    
    

95. COONS JC, Crisamore K, Adams S, Modany A, et al
    A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertension.
    Ther Adv Respir Dis. 2021;15:17534666211013688.
    PubMed    
    Abstract available
    
    

96. SANTOS-MARTINEZ LE, Gomez-Tejada RA, Murillo-Jauregui CX, Hoyos-Paladines RA, et al
    [Chronic exposure to altitude. Clinical characteristics and diagnosis].
    Arch Cardiol Mex. 2021;91:500-507.
    PubMed    
    Abstract available
    
    

97. CAI M, Li X, Dong H, Wang Y, et al
    CCR7 and its related molecules may be potential biomarkers of pulmonary arterial hypertension.
    FEBS Open Bio. 2021;11:1565-1578.
    PubMed    
    Abstract available
    
    

98. MALONEY MA, Davidson Ward SL, Su JA, Durazo-Arvizu RA, et al
    Prevalence of pulmonary hypertension on echocardiogram in children with severe obstructive sleep apnea.
    J Clin Sleep Med. 2022 Feb 28. doi: 10.5664/jcsm.9944.
    PubMed    
    Abstract available
    
    

99. SORENSEN HT, Skajaa N, Klok FA, Laugesen K, et al
    Cancer Risk in Pulmonary Hypertension Patients.
    Clin Epidemiol. 2022;14:173-177.
    PubMed    
    Abstract available
    
    

100. KARAM N, Hausleiter J
     Can Artificial Intelligence Solve Pulmonary Hypertension Paradox in Severe Tricuspid Regurgitation?
     JACC Cardiovasc Interv. 2022;15:395-396.
     PubMed    
     
     
     

101. FORTMEIER V, Lachmann M, Korber MI, Unterhuber M, et al
     Solving the Pulmonary Hypertension Paradox in Patients With Severe Tricuspid Regurgitation by Employing Artificial Intelligence.
     JACC Cardiovasc Interv. 2022;15:381-394.
     PubMed    
     Abstract available
     
     

102. SHARMA M, Callan E, Konduri GG
     Pulmonary Vasodilator Therapy in Persistent Pulmonary Hypertension of the Newborn.
     Clin Perinatol. 2022;49:103-125.
     PubMed    
     Abstract available
     
     

103. DZIKOWSKA-DIDUCH O, Kurnicka K, Lichodziejewska B, Zdonczyk O, et al
     A Novel Doppler TRPG/AcT Index Improves Echocardiographic Diagnosis of Pulmonary Hypertension after Pulmonary Embolism.
     J Clin Med. 2022;11.
     PubMed    
     Abstract available
     
     

104. VRIGKOU E, Vassilatou E, Dima E, Langleben D, et al
     The Role of Thyroid Disorders, Obesity, Diabetes Mellitus and Estrogen Exposure as Potential Modifiers for Pulmonary Hypertension.
     J Clin Med. 2022;11.
     PubMed    
     Abstract available
     
     

105. RUARO B, Baratella E, Caforio G, Confalonieri P, et al
     Chronic Thromboembolic Pulmonary Hypertension: An Update.
     Diagnostics (Basel). 2022;12.
     PubMed    
     Abstract available
     
     

106. EBERHARD M, McInnis M, de Perrot M, Lichtblau M, et al
     Dual-Energy CT Pulmonary Angiography for the Assessment of Surgical Accessibility in Patients with Chronic Thromboembolic Pulmonary Hypertension.
     Diagnostics (Basel). 2022;12.
     PubMed    
     Abstract available
     
     

107. COLON HIDALGO D, Elajaili H, Suliman H, George MP, et al
     Metabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension.
     Antioxidants (Basel). 2022;11.
     PubMed    
     Abstract available
     
     

108. BARBAGELATA L, Masson W, Bluro I, Lobo M, et al
     Prognostic role of cardiopulmonary exercise testing in pulmonary hypertension: a systematic review and meta-analysis.
     Adv Respir Med. 2022 Feb 24. pii: VM/OJS/J/84602. doi: 10.5603/ARM.a2022.0030.
     PubMed    
     Abstract available
     
     

109. ARIF R, Pandey A, Zhao Y, Arsenault-Mehta K, et al
     Treatment of pulmonary hypertension associated with COPD: a systematic review.
     ERJ Open Res. 2022;8.
     PubMed    
     Abstract available
     
     

110. XIE SS, Deng Y, Guo SL, Li JQ, et al
     Endothelial cell ferroptosis mediates monocrotaline-induced pulmonary hypertension in rats by modulating NLRP3 inflammasome activation.
     Sci Rep. 2022;12:3056.
     PubMed    
     Abstract available
     
     

111. WANG L, Han X, Wang M, Ma X, et al
     Ventilation/perfusion imaging predicts response to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
     Ann Nucl Med. 2022 Feb 22. pii: 10.1007/s12149-022-01731.
     PubMed    
     Abstract available
     
     

112. ZHUANG XL, Zhu ZL, Huang QH, Yan FR, et al
     High magnesium mitigates the vasoconstriction mediated by different types of calcium influx from monocrotaline-induced pulmonary hypertensive rats.
     Exp Physiol. 2022 Feb 22. doi: 10.1113/EP090029.
     PubMed    
     Abstract available
     
     

113. PUEBLA-ALDAMA D, Cueto-Robledo G, Barragan-Martinez MD, Roldan-Valadez E, et al
     Review of functional status and hemodynamic parameters in patients diagnosed with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) with and without Antiphospholipid Syndrome (APLS).
     Curr Probl Cardiol. 2022 Feb 19:101154. doi: 10.1016/j.cpcardiol.2022.101154.
     PubMed    
     Abstract available
     
     

114. VOS JL, Leiner T, van Dijk APJ, van der Zwaan HB, et al
     Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension.
     Int J Cardiovasc Imaging. 2022 Feb 21. pii: 10.1007/s10554-022-02555.
     PubMed    
     Abstract available
     
     

115. CHEN D, Zhang HF, Yuan TY, Sun SC, et al
     Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models.
     Acta Pharmacol Sin. 2022 Feb 21. pii: 10.1038/s41401-022-00865.
     PubMed    
     Abstract available
     
     

116. YANG JH, Harada T, Choi KH, Kato T, et al
     Peripheral Venous Pressure-Assisted Exercise Stress Echocardiography in the Evaluation of Pulmonary Hypertension During Exercise in Patients With Suspected Heart Failure With Preserved Ejection Fraction.
     Circ Heart Fail. 2022 Feb 22:CIRCHEARTFAILURE121009028.
     PubMed    
     Abstract available
     
     

117. KHAN Z, Mlawa G, Bashir M, Abumedian M, et al
     Resolution of Thyrotoxicosis-Associated Pulmonary Hypertension With Treatment of Thyrotoxicosis: A Case-Based Report and Literature Review.
     Cureus. 2022;14:e21304.
     PubMed    
     Abstract available
     
     

118. YANG D, Wang L, Jiang P, Kang R, et al
     Correlation between hs-CRP, IL-6, IL-10, ET-1, and Chronic Obstructive Pulmonary Disease Combined with Pulmonary Hypertension.
     J Healthc Eng. 2022;2022:3247807.
     PubMed    
     Abstract available
     
     

119. OTA H, Kamada H, Higuchi S, Takase K, et al
     Clinical Application of 4D Flow MR Imaging to Pulmonary Hypertension.
     Magn Reson Med Sci. 2022 Feb 19. doi: 10.2463/mrms.rev.2021-0111.
     PubMed    
     Abstract available
     
     

120. ROBERTSON L, Bunclark K, Ross RM, Cannon J, et al
     The prognostic ability of cardiac output determined by inert gas rebreathing technique in pulmonary hypertension.
     Chron Respir Dis. 2022;19:14799731221078473.
     PubMed    
     Abstract available
     
     

121. KARADAVUT S, Cetin M
     A Novel Factor in Determining the Risk of Ischemic Cerebrovascular Events in Patients with Atrial Fibrillation: Pulmonary Hypertension.
     J Stroke Cerebrovasc Dis. 2022;31:106387.
     PubMed    
     Abstract available
     
     

122. SEREDYUK VN, Vakaliuk IP, Seredyuk NM, Fedorov SV, et al
     CLINICAL PECULIARITIES AND PATHOGENETIC DETERMINANTS OF DEVELOPMENT AND PROGRESSION OF CHRONIC PULMONARY HEART WITH ARTERIAL HYPERTENSION.
     Wiad Lek. 2022;75.
     PubMed    
     Abstract available
     
     

123. DONN SM
     Persistent pulmonary hypertension of the newborn: Historical perspectives.
     Semin Fetal Neonatal Med. 2022 Feb 14:101323. doi: 10.1016/j.siny.2022.101323.
     PubMed    
     Abstract available
     
     

124. KVASLERUD AB, Gude E, Eriksen G, Andreassen AK, et al
     Diastolic Dysfunction Is Unmasked on Exercise in Patients With Asymptomatic, Severe Aortic Stenosis: An Invasive Hemodynamic Study.
     Circ Heart Fail. 2022 Feb 9:CIRCHEARTFAILURE121009253.
     PubMed    
     Abstract available
     
     

125. REDAELLI S, Magliocca A, Malhotra R, Ristagno G, et al
     Nitric oxide: Clinical applications in critically ill patients.
     Nitric Oxide. 2022;121:20-33.
     PubMed    
     Abstract available
     
     

126. MUSSA A, Carli D, Giorgio E, Villar AM, et al
     MEK Inhibition in a Newborn with RAF1-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease.
     Genes (Basel). 2021;13.
     PubMed    
     Abstract available
     
     

127. QIN T, Kong B, Dai C, Xiao Z, et al
     Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline.
     Bioengineered. 2022;13:2697-2709.
     PubMed    
     Abstract available
     
     

128. KITA T, Kitamura K
     Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases.
     Hypertens Res. 2022;45:389-400.
     PubMed    
     Abstract available
     
     

129. SHENG Y, Gong X, Zhao J, Liu Y, et al
     Effects of Crocin on CCL2/CCR2 Inflammatory Pathway in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
     Am J Chin Med. 2022;50:241-259.
     PubMed    
     Abstract available
     
     

130. PRISCO SZ, Hartweck LM, Rose L, Lima PDA, et al
     Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility.
     Circ Heart Fail. 2022;15:e008574.
     PubMed    
     Abstract available
     
     

131. VONK NOORDEGRAAF A, Channick R, Cottreel E, Kiely DG, et al
     The REPAIR Study: Effects of Macitentan on RV Structure and Function in Pulmonary Arterial Hypertension.
     JACC Cardiovasc Imaging. 2022;15:240-253.
     PubMed    
     Abstract available
     
     

132. FREED BH
     REPAIRing What We Can't See: The Need for Imaging Endpoints in PAH Clinical Trials.
     JACC Cardiovasc Imaging. 2022;15:254-256.
     PubMed    
     
     
     

133. CHEN CY, Hung CC, Chiang CH, Tsa YC, et al
     Pulmonary arterial hypertension in the elderly population.
     J Chin Med Assoc. 2022;85:18-23.
     PubMed    
     Abstract available
     
     

134. PRISCO SZ, Eklund M, Moutsoglou DM, Prisco AR, et al
     Intermittent Fasting Enhances Right Ventricular Function in Preclinical Pulmonary Arterial Hypertension.
     J Am Heart Assoc. 2021;10:e022722.
     PubMed    
     Abstract available
     
     

135. JAMIESON KL, Rose RA
     New insights into ventricular arrhythmogenesis in a pure model of pulmonary arterial hypertension.
     Heart Rhythm. 2022;19:125-126.
     PubMed    
     
     
     

136. OTSUKI S, Saito T, Taylor S, Li D, et al
     Monocyte-released HERV-K dUTPase engages TLR4 and MCAM causing endothelial mesenchymal transition.
     JCI Insight. 2021;6.
     PubMed    
     Abstract available
     
     

137. WUTTGE DM, Carlsen AL, Teku G, Wildt M, et al
     Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension.
     Rheumatology (Oxford). 2021;61:309-318.
     PubMed    
     Abstract available
     
     

138. SINGH S, Lewis MI
     Evaluating the Right Ventricle in Acute and Chronic Pulmonary Embolism: Current and Future Considerations.
     Semin Respir Crit Care Med. 2021;42:199-211.
     PubMed    
     Abstract available
     
     

139. BOON GJAM, Huisman MV, Klok FA
     Determinants and Management of the Post-Pulmonary Embolism Syndrome.
     Semin Respir Crit Care Med. 2021;42:299-307.
     PubMed    
     Abstract available
     
     

140. HAHN J, Virk HUH, Al-Azzam F, Greason K, et al
     Outcomes of Transcatheter Aortic Valve Implantation in Patients With Chronic and End-Stage Kidney Disease.
     Am J Cardiol. 2021 Nov 22. pii: S0002-9149(21)01061.
     PubMed    
     Abstract available
     
     

141. CHRISTOU H, Khalil RA
     Mechanisms of Pulmonary Vascular Dysfunction in Pulmonary Hypertension and Implications for Novel Therapies.
     Am J Physiol Heart Circ Physiol. 2022 Feb 25. doi: 10.1152/ajpheart.00021.2022.
     PubMed    
     Abstract available
     
     

142. BAZAN IS, Ardito TA, Zhang Y, Shan P, et al
     Sex Differences and Altered Mitophagy in Experimental Pulmonary Hypertension.
     Am J Physiol Lung Cell Mol Physiol. 2022 Feb 9. doi: 10.1152/ajplung.00019.2020.
     PubMed    
     Abstract available
     
     

143. SHARMA S, Lang IM
     More Evidence for Inflammatory Thrombosis in Chronic Thromboembolic Pulmonary Hypertension - Is the Embolic Hypothesis Losing Grounds?
     Am J Respir Crit Care Med. 2022 Feb 8. doi: 10.1164/rccm.202201-0001.
     PubMed    
     
     
     

144. KOLAITIS NA, Lammi M, Mazimba S, Feldman J, et al
     Human Immune Deficiency Virus-Associated Pulmonary Arterial Hypertension: A Report from the Pulmonary Hypertension Association Registry.
     Am J Respir Crit Care Med. 2022 Feb 18. doi: 10.1164/rccm.202111-2481.
     PubMed    
     
     
     

145. JUNG SM, Park KS, Kim KJ
     Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease.
     Ann Rheum Dis. 2022;81:108-116.
     PubMed    
     Abstract available
     
     

146. BALKI I, de Perrot M, Bavaghar-Zaeimi F, Nourouzpour S, et al
     Clinical Implications of Body Composition and Exercise Capacity Following Pulmonary Endarterectomy.
     Ann Thorac Surg. 2022;113:444-451.
     PubMed    
     Abstract available
     
     

147. KOVACS G, Avian A, Bachmaier G, Troester N, et al
     Severe pulmonary hypertension in COPD - impact on survival and diagnostic approach.
     Chest. 2022 Jan 26. pii: S0012-3692(22)00192-1. doi: 10.1016/j.chest.2022.
     PubMed    
     Abstract available
     
     

148. JOHNSON SW, Maron BA
     COUNTERPOINT: Did the World Symposium on Pulmonary Hypertension Get It Right in Redefining Abnormal Pulmonary Arterial Pressure? No.
     Chest. 2022;161:313-315.
     PubMed    
     
     
     

149. KOVACS G
     POINT: Did the World Symposium on Pulmonary Hypertension Get It Right in Redefining Abnormal Pulmonary Arterial Pressure? Yes.
     Chest. 2022;161:311-312.
     PubMed    
     
     
     

150. RAHAGHI FF, Kolaitis NA, Adegunsoye A, de Andrade J, et al
     Screening Strategies for Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Multidisciplinary Delphi Study.
     Chest. 2022 Feb 14. pii: S0012-3692(22)00262-8. doi: 10.1016/j.chest.2022.
     PubMed    
     Abstract available
     
     

151. LANE T, Hountras P
     A 65-Year-Old Man With Weight Loss, Peripheral Neuropathy, and Lower Extremity Swelling.
     Chest. 2022;161:e29-e34.
     PubMed    
     Abstract available
     
     

152. MURRAY E, Taylor J, Hountras P
     A Case of High-Output Heart Failure.
     Chest. 2022;161:e23-e28.
     PubMed    
     Abstract available
     
     

153. LECHARTIER B, Berrebeh N, Huertas A, Humbert M, et al
     Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension: Implications for Therapy.
     Chest. 2022;161:219-231.
     PubMed    
     Abstract available
     
     

154. ALQALYOOBI S, Liao SY, Qureshi W, Obi ON, et al
     National Temporal Trends in Hospitalization and Inpatient Mortality in Patients With Pulmonary Sarcoidosis in the United States Between 2007 and 2018.
     Chest. 2022;161:152-168.
     PubMed    
     Abstract available
     
     

155. VEITH C, Varturk-Ozcan I, Wujak M, Hadzic S, et al
     Secreted Protein Acidic and Rich in Cysteine, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
     Circulation. 2022 Feb 17. doi: 10.1161/CIRCULATIONAHA.121.057001.
     PubMed    
     Abstract available
     
     

156. GAZENGEL P, Hascoet S, Amsallem M, Savale L, et al
     Double-lung transplantation followed by delayed percutaneous repair for atrial septal defect-associated pulmonary arterial hypertension.
     Eur Respir J. 2021 Nov 4. pii: 13993003.02388-2021.
     PubMed    
     
     
     

157. RADVANSKY BM, Shah R, Feinman J, Augoustides JG, et al
     Pulmonary Hypertension in Pregnancy: A Positive Outcome with a Multidisciplinary Team and Individualized Treatment Plan.
     J Cardiothorac Vasc Anesth. 2022 Jan 3. pii: S1053-0770(21)01120.
     PubMed    
     
     
     

158. DUMITRESCU D, Koster A, Erdoes G, Denault AY, et al
     Perioperative Management of Pulmonary Hypertension During Cardiac Surgery: A Call for Interdisciplinary Networking.
     J Cardiothorac Vasc Anesth. 2022 Jan 17. pii: S1053-0770(22)00048.
     PubMed    
     
     
     

159. STEIN ML, Staffa SJ, O'Brien Charles A, Callahan R, et al
     Anesthesia in Children With Pulmonary Hypertension: Clinically Significant Serious Adverse Events Associated With Cardiac Catheterization and Noncardiac Procedures.
     J Cardiothorac Vasc Anesth. 2022 Jan 13. pii: S1053-0770(22)00044.
     PubMed    
     Abstract available
     
     

160. LUO S, Kan J, Zhang J, Ye P, et al
     Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
     J Cardiovasc Pharmacol. 2021;78:253-262.
     PubMed    
     Abstract available
     
     

161. KEMELBEKOV K, Musaev Y, Bektenova G, Datkayeva G, et al
     Comparative Results of Treatment and Complications: Pedea in Open Ductus Arteriosus in Premature Infants.
     J Cardiovasc Pharmacol. 2021;78:e722-e728.
     PubMed    
     Abstract available
     
     

162. ADIE SK, Abdul-Aziz AA, Ketcham SW, Moles VM, et al
     Considerations for inotrope and vasopressor use in critically ill patients with pulmonary arterial hypertension.
     J Cardiovasc Pharmacol. 2021 Oct 6. pii: 00005344-900000000-98139.
     PubMed    
     Abstract available
     
     

163. KHIRFAN G, Li M, Wang X, Dweik RA, et al
     Is pulmonary vascular resistance index better than pulmonary vascular resistance in predicting outcomes in pulmonary arterial hypertension?
     J Heart Lung Transplant. 2021;40:614-622.
     PubMed    
     Abstract available
     
     

164. JEROME LP, Severine F, Olaf M, Pauline P, et al
     Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the implementation of a high-priority allocation program in France.
     J Heart Lung Transplant. 2021 Mar 26. pii: S1053-2498(21)02239.
     PubMed    
     Abstract available
     
     

165. IRELAND CG, Damico RL, Kolb TM, Mathai SC, et al
     Exercise right ventricular ejection fraction predicts right ventricular contractile reserve.
     J Heart Lung Transplant. 2021;40:504-512.
     PubMed    
     Abstract available
     
     

166. AIRHART S, Badie N, Doyle M, Correa-Jacque P, et al
     Assessing hemodynamic response to submaximal exercise in pulmonary arterial hypertension patients using an implantable hemodynamic monitor.
     J Heart Lung Transplant. 2021;40:430-434.
     PubMed    
     Abstract available
     
     

167. HUG KP, Gerry Coghlan J, Cannon J, Taboada D, et al
     Serial right heart catheter assessment between balloon pulmonary angioplasty sessions identify procedural factors that influence response to treatment.
     J Heart Lung Transplant. 2021;40:1223-1234.
     PubMed    
     Abstract available
     
     

168. FURFARO D, Rosenzweig EB, Shah L, Robbins H, et al
     Lung transplantation disparities based on diagnosis for patients bridging to transplant on extracorporeal membrane oxygenation.
     J Heart Lung Transplant. 2021 Aug 25. pii: S1053-2498(21)02459.
     PubMed    
     Abstract available
     
     

169. BENAZZO A, Bajorek L, Morscher A, Schrutka L, et al
     Early implementation of renal replacement therapy after lung transplantation does not impair long-term kidney function in patients with idiopathic pulmonary arterial hypertension.
     J Thorac Cardiovasc Surg. 2021 Jun 1. pii: S0022-5223(21)00879.
     PubMed    
     Abstract available
     
     

170. LUKS AM, Hackett PH
     Medical Conditions and High-Altitude Travel.
     N Engl J Med. 2022;386:364-373.
     PubMed    
     
     
     

171. BARBEAU S, Porto Ribeiro T, Gilbert G, Cardouat G, et al
     [Involvement of the Piezo1 and TRPV4 stretch-activated channels in pulmonary hypertension].
     Rev Mal Respir. 2022 Feb 9. pii: S0761-8425(22)00034.
     PubMed    
     Abstract available
     
     

172. HEUKELS P, Corneth OBJ, van Uden D, van Hulst JAC, et al
     Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension.
     Thorax. 2021;76:1209-1218.
     PubMed    
     Abstract available
     
     

173. POVEDA D, Ruiz E, Fernandez AM, Gonzalez FJ, et al
     Lung Transplantation in a Young Patient With Pulmonary Artery Hypertension After Arterial Switch Operation: A Case Report.
     Transplant Proc. 2021 Dec 16. pii: S0041-1345(21)00820.
     PubMed    
     Abstract available
     
     

174. TAKIGAMI M, Tsubata H, Nakanishi N, Matsubara Y, et al
     The effectiveness of scoring balloon angioplasty in the treatment of chronic thromboembolic pulmonary hypertension.
     PLoS One. 2022;17:e0263244.
     PubMed    
     Abstract available